CAR T cell therapy for pediatric brain cancer warrants further study

Researchers at Texas Children’s Cancer Center and the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children’s Hospital and Houston Methodist Hospital developed an augmented CAR T cell therapy targeting the GD2 antigen, which is highly expressed in DMG and other CNS tumors.

Read more: https://www.bcm.edu/news/car-t-cell-therapy-for-pediatric-brain-cancer-warrants-further-study